LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE LIPIKAR ECZEMA SOOTHING RELIEF- oatmeal cream 
L'Oreal USA Products Inc

----------

Drug Facts

Active ingredient

Colloidal oatmeal 1%

Purpose

Skin protectant

Uses

Warnings

For external use only

When using this product

do not get into eyes

Stop use and ask a doctor if

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

apply as needed

Inactive ingredients

water, shea butter, glycerin, dimethicone, mineral oil, niacinamide, cetearyl alcohol, rapeseed seed oil, ammonium polyacryloyldimethyl taurate, PEG-100 stearate, glyceryl stearate, tocopherol, sodium benzoate, PEG-20 methyl glucose sesquistearate, dimethiconol, mannose, xanthan gum, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, capryloyl glycine, microcrystalline wax, sorbitan tristearate, paraffin, discodium EDTA, vitreoscilla ferment, citric acid

Questions or comments?

1-888-LRP LABO

1-888-577-5226

Monday - Friday (9 a.m. - 5 p.m. EST)

image of a label

image of a label
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE LIPIKAR ECZEMA SOOTHING RELIEF 
oatmeal cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-621
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OATMEAL (UNII: 8PI54V663Y) (OATMEAL - UNII:8PI54V663Y) OATMEAL10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SHEA BUTTER (UNII: K49155WL9Y)  
GLYCERIN (UNII: PDC6A3C0OX)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
MINERAL OIL (UNII: T5L8T28FGP)  
NIACINAMIDE (UNII: 25X51I8RD4)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CANOLA OIL (UNII: 331KBJ17RK)  
PEG-100 STEARATE (UNII: YD01N1999R)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
TOCOPHEROL (UNII: R0ZB2556P8)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
PEG-20 METHYL GLUCOSE SESQUISTEARATE (UNII: 0345752X7U)  
DIMETHICONOL (100000 CST) (UNII: OSA9UP217S)  
MANNOSE, D- (UNII: PHA4727WTP)  
XANTHAN GUM (UNII: TTV12P4NEE)  
PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)  
CAPRYLOYL GLYCINE (UNII: 8TY5YO42NJ)  
MICROCRYSTALLINE WAX (UNII: XOF597Q3KY)  
SORBITAN TRISTEARATE (UNII: 6LUM696811)  
PARAFFIN (UNII: I9O0E3H2ZE)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49967-621-011 in 1 CARTON11/21/201711/21/2017
15 mL in 1 TUBE; Type 0: Not a Combination Product
2NDC:49967-621-02200 mL in 1 TUBE; Type 0: Not a Combination Product11/21/2017
3NDC:49967-621-031 in 1 CARTON11/21/2017
33 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01611/21/2017
Labeler - L'Oreal USA Products Inc (002136794)
Establishment
NameAddressID/FEIBusiness Operations
COSMETIQUE ACTIVE PRODUCTION282658798manufacture(49967-621) , pack(49967-621)

Revised: 12/2023
Document Id: fc1b324e-cdc1-420c-a2c2-750e09fc0dd5
Set id: f7b71606-0044-4729-82e8-4514331806a0
Version: 4
Effective Time: 20231211
 
L'Oreal USA Products Inc